Immune-excluded and immune-suppressive tumor microenvironments: mechanisms, spatial biomarkers, and therapeutic rewiring - Top-Institutions - MDSpire

Immune-excluded and immune-suppressive tumor microenvironments: mechanisms, spatial biomarkers, and therapeutic rewiring

  • By

  • Bo Wang

  • Haixin Ding

  • Yutong Li

  • Xue Zhao

  • Pengling Ge

  • May 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Cancer Research

  • #2

    Stanford University
    Stanford University

    Stanford, California

    Key Differentiators

    • Oncology
    • Immunology

  • #3

    Dusseldorf Central Nervous System Tumor Tissue Bank
    Dusseldorf Central Nervous System Tumor Tissue Bank

    Düsseldorf, North Rhine-Westphalia

    Key Differentiators

    • Neuroscience
    • Oncology

  • #4

    EORTC 1419 ETERNITY Study
    EORTC 1419 ETERNITY Study

    Brussels, Brussels-Capital Region

    Key Differentiators

    • Oncology
    • Clinical Trials

  • #5

    The University of California, San Francisco
    The University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Oncology
    • Genomics

Original Source(s)

Immune-excluded and immune-suppressive tumor microenvironments: mechanisms, spatial biomarkers, and therapeutic rewiring

  • by Bo Wang, Haixin Ding, Yutong Li, Xue Zhao, Pengling Ge

  • May 22, 2026

Related Content

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Potential targets for boron transport in boron neutron capture therapy

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases